More than 150 medicines, including drugs to treat hypertension (Inderal), antibiotics (Clamoxyl), and hepatitis A and B vaccines, are banned from export, according to an information circular from the National Drug Administration released this Monday.
An information circular from the National Administration of Medicines and Health Products (Infarmed), effective Tuesday, banned the export of 154 medicines, up 24 from March.
The circular updates drugs whose exports are temporarily suspended, a list that is compiled monthly and includes drugs that were not available in the previous month and whose impact is considered medium or high in accordance with the provision on availability.
Updated this Monday, the list includes 154 drugs of various categories and active ingredients, including drugs for the treatment of diabetes, antibacterials, intestinal anti-inflammatory drugs, analgesics and antipyretics, drugs for urinary incontinence, hypertension, diphtheria, tetanus and pertussis vaccines. , rotavirus vaccines, hepatitis A and hepatitis B.
Infarmed monitors stockouts, disruptions and discontinuance information on a daily basis in order to timely identify and prevent critical situations that may affect the availability of medicines.
“As part of accessibility control, one of the measures taken to ensure a balance between regular supply to the market and the export of medicines is compliance with the Prior Notice Regulation for drug transactions outside the country,” the report says. the authority of medicine in a note published on the “website”.
For Infarmed, “Ensuring citizens have access to the medicines they need is one of the most relevant aspects of the fundamental right to health care.”
In this sense, he adds, “all drug traffickers must guarantee continuous and adequate access to drugs as part of public service provision.”
Infarmed is part of the European network of points of contact for competent national authorities, the European Medicines Agency (EMA) and the European Commission, which has been used since April 2019 to share information about supply interruptions and problems with the availability of authorized medicines in the European Union.
Author: Portuguese
Source: CM Jornal
I’m Tifany Hawkins, a professional journalist with years of experience in news reporting. I currently work for a prominent news website and write articles for 24NewsReporters as an author. My primary focus is on economy-related stories, though I am also experienced in several other areas of journalism.